TY - JOUR
T1 - Restoration of positioning control following Disabled-2 expression in ovarian and breast tumor cells
AU - Sheng, Zejuan
AU - Sun, Wenping
AU - Smith, Elizabeth
AU - Cohen, Cynthia
AU - Sheng, Zeqi
AU - Xu, Xiang Xi
N1 - Funding Information:
We thank Drs Andrew Fischer and Wayne Harris for their suggestions and discussion of the experiments and results. We also thank Ms Jackie Bradshaw for her assistance in preparation of this manuscript. These studies were supported by NCI/NIH grants to XX Xu (CA 75389 and CA 79716).
PY - 2000/10/5
Y1 - 2000/10/5
N2 - The physical interaction of epithelial cells with the basement membrane ensures correct positioning and acts as a survival factor for epithelial cells. Cells that detach from the basement membrane often undergo apoptosis; however, in carcinomas, this positional control is absent, permitting disorganized cell proliferation. In the majority of breast and ovarian carcinomas (85-90%), the expression of a candidate tumor suppressor, Disabled-2 (Dab2), is frequently lost. The Dab2-negative tumor cells are no longer in contact with an intact basement membrane, as indicated by the absence of collagen IV (in about 90% of cases). However, in the subset (10-15%) of ovarian tumors in which Dab2 expression is positive, the presence of a basement membrane-like structure around tumor cells was observed. Recombinant adenovirus-mediated expression of Dab2 was used in Dab2-negative ovarian and breast cancer cells, and re-expression of Dab2 was found to lead to cell death or growth arrest. Dab2 expression suppressed MAPK activation and c-los expression. Plating the infected cells on a basement membrane matrigel rescued the cells from death and growth arrest. Thus, Dab2 exhibits a negative activity for cell growth and survival, which can be countered by attachment of the cells to basement membrane matrix. We conclude that Dab2 functions in cell positioning control and mediates the exigency for basement membrane attachment of epithelial cells. Loss of Dab2 may contribute to the basement membrane-independent, disorganized proliferation of tumor cells in ovarian and breast carcinomas.
AB - The physical interaction of epithelial cells with the basement membrane ensures correct positioning and acts as a survival factor for epithelial cells. Cells that detach from the basement membrane often undergo apoptosis; however, in carcinomas, this positional control is absent, permitting disorganized cell proliferation. In the majority of breast and ovarian carcinomas (85-90%), the expression of a candidate tumor suppressor, Disabled-2 (Dab2), is frequently lost. The Dab2-negative tumor cells are no longer in contact with an intact basement membrane, as indicated by the absence of collagen IV (in about 90% of cases). However, in the subset (10-15%) of ovarian tumors in which Dab2 expression is positive, the presence of a basement membrane-like structure around tumor cells was observed. Recombinant adenovirus-mediated expression of Dab2 was used in Dab2-negative ovarian and breast cancer cells, and re-expression of Dab2 was found to lead to cell death or growth arrest. Dab2 expression suppressed MAPK activation and c-los expression. Plating the infected cells on a basement membrane matrigel rescued the cells from death and growth arrest. Thus, Dab2 exhibits a negative activity for cell growth and survival, which can be countered by attachment of the cells to basement membrane matrix. We conclude that Dab2 functions in cell positioning control and mediates the exigency for basement membrane attachment of epithelial cells. Loss of Dab2 may contribute to the basement membrane-independent, disorganized proliferation of tumor cells in ovarian and breast carcinomas.
KW - Basement membrane
KW - Cell positioning
KW - Disabled-2
KW - Extracellular matrix
KW - Ras pathway
UR - http://www.scopus.com/inward/record.url?scp=0034609730&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034609730&partnerID=8YFLogxK
U2 - 10.1038/sj.onc.1203853
DO - 10.1038/sj.onc.1203853
M3 - Article
C2 - 11039902
AN - SCOPUS:0034609730
VL - 19
SP - 4847
EP - 4854
JO - Oncogene
JF - Oncogene
SN - 0950-9232
IS - 42
ER -